Impax Laboratories Inc. v. Lannett Holdings Inc.
Impax Laboratories Inc. v. Lannett Holdings Inc.
Impax Laboratories Inc. v. Lannett Holdings Inc.
Opinion
United States Court of Appeals for the Federal Circuit ______________________ July 2, 2018 ERRATUM ______________________ Appeal No. 2017-2020 IMPAX LABORATORIES INC., ASTRAZENECA AB, ASTRAZENECA UK LIMITED, Plaintiffs-Appellees v. LANNETT HOLDINGS INC., LANNETT COMPANY INC., Defendants-Appellants ______________________ Decided: June 28, 2018 Precedential Opinion ______________________ Please make the following change: On page 2, line 7, U.S. Patent 6,760,237 is changed to U.S. Patent 6,750,237.
Case-law data current through December 31, 2025. Source: CourtListener bulk data.